Traitement Anémie aplastique en Turquie — recevez 3 correspondances personnalisées de cliniques

Aplastic anemia is curable in Turkey through bone marrow transplantation and immunosuppressive therapy. Turkish hospitals report survival rates between 80% and 99% for transplants. Success relies on advanced allogeneic stem cell procedures and JCI-accredited hematology departments following international protocols.

• Success rates: Turkish centers report transplant success rates exceeding 95% for certain cases.
• Primary cure: Allogeneic bone marrow transplantation replaces damaged marrow with healthy donor cells.
• Survival data: Turkey reports a 72.6% five-year overall survival rate for these patients.
• Standard protocols: Facilities like Anadolu Medical Center maintain affiliations with Johns Hopkins Medicine.

Bookimed Expert Insight: Turkish hematology centers excel because they operate as high-volume transplant hubs. Memorial Healthcare Group manages international donor bank cooperation to find matches faster. This infrastructure supports complicated cases that smaller regional clinics cannot handle. Doctors like those at Acibadem typically treat hundreds of blood disorders annually.

Patient Consensus: Patients value the clear communication regarding donor matching timelines. They highlight that the integrated care teams make long isolation periods more comfortable.

Turkish hematology centers report a 72.6% 5-year survival rate for aplastic anemia. Bone marrow transplant success rates range from 80% to 99% at leading facilities. These outcomes depend on donor matching, patient age, and the use of JCI-accredited transplant protocols.

• Overall survival: Multiple centers report a 72.6% 5-year survival rate for treated patients.
• Transplant success: Specialized teams report success rates reaching 97% for unrelated donor transplants.
• Center performance: Memorial Sisli reports a 91.5% success rate for bone marrow procedures.
• Clinical volume: Anadolu Medical Center has performed over 3,000 successful transplants to date.

Bookimed Expert Insight: Success rates in Turkey are highest at centers with specialized stem cell freezing units. For example, Liv Hospital achieves 97% success by using advanced cell processing technology. Patients should prioritize clinics with specific experience in unrelated donor matching for better results.

Patient Consensus: Patients often emphasize that early intervention and rapid donor matching are vital. They feel more confident choosing Turkish clinics that offer comprehensive post-transplant monitoring and infection control.

Anadolu Medical Center and Memorial Bahcelievler are leading centers for aplastic anemia in Turkey. These hospitals feature high-volume bone marrow transplant units. Anadolu alone performs 250+ transplants yearly. Facilities maintain JCI accreditation and partnerships with institutions like Johns Hopkins Medicine.

• Anadolu Medical Center: Over 3,000 bone marrow transplants performed. Prof. Dr. Zafer Gulbas leads.
• Memorial Bahcelievler: Reports success rates of 80% to 90%. Focuses on pediatric hematology cases.
• Liv Hospital: Features specialized therapeutic apheresis centers. Reports 95% success for unrelated donors.
• Medipol Mega: Maintains adult and pediatric transplant units. Success rates range from 91% to 92%.

Bookimed Expert Insight: Anadolu Medical Center stands out because it combines high volume with specialized certification. It is the only center in Turkey to hold both JCI and OECI (Organization of European Cancer Institutes) accreditations. Prof. Dr. Zafer Gulbas has 40+ years of experience. This combination of institutional credentials and senior expertise is rare globally.

Patient Consensus: Patients note the peace of mind provided by HEPA-filtered rooms during recovery. Many emphasize that having a translator present during daily doctor rounds makes the transplant process much easier.

Medical travelers should plan for a total stay of 3 to 6 months in Turkey. This includes 4 to 8 weeks of intensive inpatient hospitalization. An additional 1 to 3 months of local outpatient monitoring is required after discharge. Travel readiness typically occurs once blood counts stabilize.

• Preparation phase: Pre-transplant conditioning including chemotherapy usually takes 10 to 15 days.
• Hospital isolation: Inpatient stays often last 30 to 60 days in sterile rooms.
• Donor recovery: Related donors should expect to stay 2 to 4 weeks for follow-up.
• Monitoring frequency: Outpatients visit the clinic several times weekly for blood tests.

Bookimed Expert Insight: Patient volume impacts available accommodations. Top centers like Anadolu Medical Center or Medicana International receive high international requests. Secure local housing at least 4 weeks before the transplant. Many clinics include several nights in the hospital, but long-term recovery requires separate off-site lodging.

Patient Consensus: Patients emphasize the importance of staying near the clinic. Having a dedicated caregiver helps manage the frequent trips for blood tests during outpatient recovery.

Key aplastic anemia specialists in Turkey include Prof. Dr. Zafer Gulbas and Prof. Dr. Burhan Ferhanoglu. These experts practice at major centers in Istanbul and Ankara. Many hold prestigious certifications. Most have over 25 years of specialized hematology and transplantation experience.

• Prof. Dr. Zafer Gulbas: Practices at Anadolu Medical Center. He has over 45 years of experience.
• Prof. Dr. Burhan Ferhanoglu: Based at American Hospital. He specializes in bone marrow transplantation.
• Prof. Dr. Sebnem Izmir Guner: Expert at Hisar Hospital. She has over 30 years in hematology.
• Prof. Dr. Betul Tavil: Pediatric specialist at Memorial Hospital. She focuses on pediatric bone marrow failure.

Bookimed Expert Insight: Turkish hematology thrives on long-term leadership. Most key specialists have led their departments for over 20 years. Prof. Dr. Zafer Gulbas even founded the transplant center at his clinic. This continuity ensures patients receive care from doctors who established the national protocols. It also explains why these clinics maintain such high volumes of complex cases.

Patient Consensus: Patients note the relief of finding doctors who trained at top international sites. They often mention that coordinated care makes the transplant process feel much less overwhelming.